Jack Ayre
Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs
Ayre, Jack; Redmond, Joanna M; Vitulli, Giovanni; Tomlinson, Laura; Weaver, Richard; Comeo, Eleonora; Bosquillon, Cynthia; Stocks, Michael J.
Authors
Joanna M Redmond
Giovanni Vitulli
Laura Tomlinson
Richard Weaver
Eleonora Comeo
Dr CYNTHIA BOSQUILLON cynthia.bosquillon@nottingham.ac.uk
ASSISTANT PROFESSOR
Professor MICHAEL STOCKS MICHAEL.STOCKS@NOTTINGHAM.AC.UK
PROFESSOR OF MEDICINAL CHEMISTRY AND DRUG DISCOVERY
Abstract
A major limitation of pulmonary delivery is that drugs can exhibit suboptimal pharmacokinetic profiles resulting from rapid elimination from the pulmonary tissue. This can lead to systemic side effects and a short duration of action. A series of dibasic dipeptides attached to the poorly lung-retentive muscarinic M3 receptor antagonist piperidin-4-yl 2-hydroxy-2,2-diphenylacetate (1) through a pH-sensitive-linking group have been evaluated. Extensive optimization resulted in 1-(((R)-2-((S)-2,6-diaminohexanamido)-3,3-dimethylbutanoyl)oxy)ethyl 4-(2-hydroxy-2,2-diphenylacetoxy)piperidine-1-carboxylate (23), which combined very good in vitro stability and very high rat lung binding. Compound 23 progressed to pharmacokinetic studies in rats, where, at 24 h post dosing in the rat lung, the total lung concentration of 23 was 31.2 μM. In addition, high levels of liberated drug 1 were still detected locally, demonstrating the benefit of this novel prodrug approach for increasing the apparent pharmacokinetic half-life of drugs in the lungs following pulmonary dosing.
Citation
Ayre, J., Redmond, J. M., Vitulli, G., Tomlinson, L., Weaver, R., Comeo, E., Bosquillon, C., & Stocks, M. J. (2022). Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs. Journal of Medicinal Chemistry, 65(14), 9802-9818. https://doi.org/10.1021/acs.jmedchem.2c00416
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 24, 2022 |
Online Publication Date | Jul 7, 2022 |
Publication Date | Jul 28, 2022 |
Deposit Date | Jul 1, 2022 |
Publicly Available Date | Jul 8, 2023 |
Journal | Journal of medicinal chemistry |
Print ISSN | 0022-2623 |
Electronic ISSN | 1520-4804 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 65 |
Issue | 14 |
Pages | 9802-9818 |
DOI | https://doi.org/10.1021/acs.jmedchem.2c00416 |
Keywords | Drug Discovery; Molecular Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/8769944 |
Publisher URL | https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00416 |
Files
Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs
(3.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung
(2019)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search